Abstract

This statement summarises a recommendation from the Joint Committee on Vaccination and Immunisation (JCVI) on an immunisation to prevent serious Respiratory Syncytial Virus (RSV) disease in at risk pre-term infants. It follows a request from the Department of Health that the JCVI consider cost-effective immunisation strategies to protect against RSV. Source: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_120395.pdf

  • Europe
  • United Kingdom
  • health policy